WADA Prohibited List Overview
The World Anti-Doping Agency (WADA) maintains a comprehensive prohibited list that includes many research peptides. Athletes and sports researchers must understand these restrictions to avoid inadvertent violations.
Growth Hormone Releasing Peptides
All growth hormone releasing peptides are prohibited under WADA regulations. This includes Sermorelin, Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. These peptides stimulate natural GH production, providing potential performance advantages.
Hormone and Metabolic Modulators
Peptides affecting hormone production like hCG, Gonadorelin, and Kisspeptin-10 are banned due to their ability to stimulate testosterone production or other hormonal pathways. Metabolic peptides like Semaglutide may also face scrutiny for weight management effects.
Prohibited Anytime vs In-Competition
Most performance-enhancing peptides are prohibited both in-competition and out-of-competition. However, some therapeutic peptides may have different restrictions based on timing and medical necessity.
Therapeutic Use Exemptions (TUEs)
Athletes requiring medically necessary peptides may apply for Therapeutic Use Exemptions. Approved peptides like Oxytocin for legitimate medical conditions may qualify for TUE consideration with proper documentation.
Detection Methods
Modern anti-doping laboratories can detect most prohibited peptides through advanced mass spectrometry techniques. Detection windows vary by peptide but can extend weeks to months depending on the compound.
Research Implications
Sports researchers must consider WADA restrictions when designing studies involving athletes. Even cosmetic peptides like GHK-Cu should be evaluated for potential indirect performance effects.
This information is for research purposes only and not anti-doping advice. Consult WADA resources and qualified officials for competitive sports guidance.